Torpedo_number Report for: 72drome-ACHE
human-ACHE
: (kinetic parameters)
Mutation | Kin. | Type | Evaluation system | Effect | Reference |
D74N | kin | sdm | Omega loop | No effect | Velan_1996_FEBS.Lett_395_22 |
D74N | kin | sdm | Peripheral Anionic Site | Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165, Shafferman_1993_Proc.Med.Def.Biosci.Rev_3_1097, Shafferman_1995_5th.ChE.Meeting.Madras__189, Shafferman_1996_Biochem.J_318_833 |
D74N | kin | sdm | Substrate inhibition | Signal transduction Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165, Shafferman_1993_Proc.Med.Def.Biosci.Rev_3_1097, Shafferman_1995_5th.ChE.Meeting.Madras__189, Shafferman_1996_Biochem.J_318_833 |
D74N | kin | sdm | Heat and pressure stability | strengthened heat or pressure stability | Clery-Barraud_2002_Eur.J.Biochem_269_4297 |
D74N | kin | sdm | VX stereospecificity | decrease in stereoselectivity | Ordentlich_2004_Biochemistry_43_11255, Ordentlich_2005_Chem.Biol.Interact_157-158_191 |
D74N | kin | sdm | oxime interaction | reactivation of tabun-inhibited human AChE. Rate constant 20-fold decreased for K027 and HLo-7. Unable to facilitate HI-6-mediated reactivation of tabun-hAChE | Artursson_2009_Toxicology_265_108 |
D74K | kin | sdm | Peripheral Anionic Site | Peripheral Anionic Site/signal transduction/allosteric modulation/substrate inhibition. Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165 |
D74K | kin | sdm | Signal transduction | Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165 |
D74G | kin | sdm | Peripheral Anionic Site | Peripheral Anionic Site/signal transduction/allosteric modulation/substrate inhibition. Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165 |
D74G | kin | sdm | Signal transduction | Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165 |
D74E | kin | sdm | Peripheral Anionic Site | Peripheral Anionic Site/signal transduction/allosteric modulation. Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165 |
D74E | kin | sdm | Signal transduction | Affects conformation of active site and PAS | Shafferman_1992_EMBO.J_11_3561, Shafferman_1992_4th.ChE.Meeting.Eilat__165 |
D74E | kin | sdm | VX stereospecificity | no effect in stereoselectivity | Ordentlich_2005_Chem.Biol.Interact_157-158_191 |
D74E | kin | sdm | oxime interaction | reactivation of tabun-inhibited human AChE. Unable to facilitate HI-6-mediated reactivation of tabun-hAChE | Artursson_2009_Toxicology_265_108 |
D74N/ W286A | | sdm | Peripheral Anionic Site | cooperativity of mutations D74 W286 10+4 increase Ki | Shafferman_1995_5th.ChE.Meeting.Madras__189 |
D74N/ Y341A | | sdm | Peripheral Anionic Site | no cooperativity D74 Y341 | Shafferman_1995_5th.ChE.Meeting.Madras__189 |
D74N/ W286A/ Y341A | | sdm | Peripheral Anionic Site | cooperativity of mutations on D74 W286 for bisquaternary PAS inhib | Shafferman_1995_5th.ChE.Meeting.Madras__189 |
human-BCHE
: (kinetic parameters)
Mutation | Kin. | Type | Evaluation system | Effect | Reference |
D70H | | nat | Peripheral anionic site | Natural variant Higher Km for charged substrates | Boeck_2002_Ann.Clin.Biochem_39_154 |
D70G | kin | sdm, nat | Succinylthiocholine binding | Higher Km for charged substrates | Masson_1997_Biochemistry_36_2266 |
D70G | kin | sdm, nat | Peripheral Anionic Site | Higher Km for substrates | Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423 |
D70G | kin | sdm, nat | Succinylcholine hydrolysis | Low hydrolysis | McGuire_1989_Proc.Natl.Acad.Sci.U.S.A_86_953, Neville_1990_J.Neurosci.Res_27_452, Neville_1992_EMBO.J_11_1641, Ehrlich_1994_Genomics_22_288, Masson_1995_5th.ChE.Meeting.Madras__230 |
D70G | kin | sdm, nat | Atypical variant | Low hydrolysis | McGuire_1989_Proc.Natl.Acad.Sci.U.S.A_86_953, Neville_1990_J.Neurosci.Res_27_452, Neville_1992_EMBO.J_11_1641, Ehrlich_1994_Genomics_22_288, Masson_1995_5th.ChE.Meeting.Madras__230 |
D70G | kin | sdm, nat | Dibucaine inhibition | Low inhibition | McGuire_1989_Proc.Natl.Acad.Sci.U.S.A_86_953, Neville_1990_J.Neurosci.Res_27_452, Neville_1992_EMBO.J_11_1641, Ehrlich_1994_Genomics_22_288 |
D70G | kin | sdm, nat | Aging | D70 and E197 function like check valves for water | Masson_1999_Chem.Biol.Interact_119-120_17 |
D70G | kin | sdm, nat | Aging | D70G increases half-life of aging by DFP 8 times | Masson_1997_Biochem.J_327_601 |
D70G | kin | sdm, nat | Aspirin hydrolysis | | Masson_1998_Biochim.Biophys.Acta_1387_41 |
D70N | | sdm | Succinylthiocholine binding | Higher Km lower kcat | Masson_1997_Biochemistry_36_2266 |
D70K | | sdm | Succinylthiocholine binding | Higher Km | Masson_1997_Biochemistry_36_2266 |
D70K | | sdm | Aspirin hydrolysis | | Masson_1998_Biochim.Biophys.Acta_1387_41 |
D70Y | | sdm | Peripheral Anionic site | interraction 70/332 | Masson_1999_Biochim.Biophys.Acta_1433_281 |
D70G/ Y332A | | sdm | Peripheral Anionic site | interraction 70/332 | Masson_1999_Biochim.Biophys.Acta_1433_281 |
D70Y/ Y332D | | sdm | Peripheral Anionic site | interraction 70/332 | Masson_1999_Biochim.Biophys.Acta_1433_281 |
D70G/ Y114H | | sdm | Dibucaine inhibition, Succinylcholine hydrolysis | Restores function to D70 mutants | Neville_1992_EMBO.J_11_1641 |
D70G/ S425P | | sdm | Succinylcholine hydrolysis/Dibucaine inhibition | S425P exaggerates D70G effects of dibucaine and succinylcholine resistance | Gnatt_1990_Cancer.Res_50_1983, Neville_1990_J.Neurosci.Res_27_452, Neville_1992_EMBO.J_11_1641, Gnatt_1990_Cancer.Res_50_1983, Schwarz_1995_Pharmacol.Th_67_283 |
D70G/ F561Y | | sdm | Succinylcholine hydrolysis | mutation at 561 restores binding of inhibitors on 70 mutant | Neville_1992_EMBO.J_11_1641 |
D70G/ Y114H/ S425P | | sdm | Succinylcholine hydrolysis Dibucaine inhibition | mutations at 561 and 114 restore binding of inhibitors on 70 mutant | Neville_1992_EMBO.J_11_1641, Schwarz_1995_Pharmacol.Ther_67_283 |
D70G/ Y114H/ F561Y | | sdm | Succinylcholine hydrolysis | mutations at 561 and 114 restore binding of inhibitors on 70 mutant | Neville_1992_EMBO.J_11_1641 |
D70G/ Y114H/ F561Y | | sdm | Dibucaine inhibition | mutations at 561 and 114 restore binding of inhibitors on 70 mutant | Neville_1992_EMBO.J_11_1641 |
D70G/ Y114H/ F561Y | | sdm | Natural mutation | Succinylcholine hydrolysis Dibucaine inhibition | Neville_1992_EMBO.J_11_1641 |
D70G/ E441G/ E443Q | | sdm | Succinylcholine hydrolysis | Catalysis reduced activity/Succinylcholine hydrolysis/Dibucaine inhibition 441 and 443 bind succinylcholine but mutant do not bind dibucaine | Neville_1992_EMBO.J_11_1641 |
D70G/ E441G/ E443Q | | sdm | Catalysis | Reduced activity | Neville_1992_EMBO.J_11_1641 |
D70G/ A539T | | nat | Natural mutation | A539T co appears with D70G natural mutation | Bartels_1992_Am.J.Hum.Genet_50_1086 |
mouse-ACHE
: (kinetic parameters)
torca-ACHE
|
|